Efficacy and Safety Of AGE ZERO™ EXOSOMES To Treat Men and Women With Androgenetic Alopecia

Inclusion Criteria: * Participant is experiencing hair loss and is diagnosed with Androgenetic Alopecia. Exclusion Criteria: * Patients cannot have taken any medications, therapies, or treatment modalities of any kind to treat hair loss in the last six months. * Patients cannot have open wounds, eczema, or psoriatic plaques on the treatment area of the scalp. * Patients who are undergoing or have undergone chemotherapy and or radiation therapy within the past 6 months * Patients with a history of an autoimmune bullous disorder (having auto-antibodies to Dsg-1 or Dsg-3) * Patients who are currently immunocompromised or have a low white count making patients prone to infections.